Metal drugs and the anticancer immune response
B Englinger, C Pirker, P Heffeter, A Terenzi… - Chemical …, 2018 - ACS Publications
The immune system deploys a multitude of innate and adaptive mechanisms not only to
ward off pathogens but also to prevent malignant transformation (“immune surveillance”) …
ward off pathogens but also to prevent malignant transformation (“immune surveillance”) …
[HTML][HTML] Effective and safe proton pump inhibitor therapy in acid-related diseases–a position paper addressing benefits and potential harms of acid suppression
Background The introduction of proton pump inhibitors (PPIs) into clinical practice has
revolutionized the management of acid-related diseases. Studies in primary care and …
revolutionized the management of acid-related diseases. Studies in primary care and …
Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1 profile in a TLR4-dependent manner
CW Wanderley, DF Colon, JPM Luiz, FF Oliveira… - Cancer research, 2018 - AACR
Paclitaxel is an antineoplastic agent widely used to treat several solid tumor types. The
primary mechanism of action of paclitaxel is based on microtubule stabilization inducing cell …
primary mechanism of action of paclitaxel is based on microtubule stabilization inducing cell …
Understanding and targeting the disease‐related RNA binding protein human antigen R (HuR)
Altered gene expression is a characteristic feature of many disease states such as
tumorigenesis, and in most cancers, it facilitates cancer cell survival and adaptation …
tumorigenesis, and in most cancers, it facilitates cancer cell survival and adaptation …
[HTML][HTML] Chemotherapy-induced constipation and diarrhea: pathophysiology, current and emerging treatments
Gastrointestinal (GI) side-effects of chemotherapy are a debilitating and often overlooked
clinical hurdle in cancer management. Chemotherapy-induced constipation (CIC) and …
clinical hurdle in cancer management. Chemotherapy-induced constipation (CIC) and …
Adjunctive treatments for the prevention of chemotherapy-and radiotherapy-induced mucositis
M Thomsen, L Vitetta - Integrative Cancer Therapies, 2018 - journals.sagepub.com
Background: Chemoradiotherapy-associated mucositis can manifest as pain, inflammation,
dysphagia, diarrhea, weight loss, rectal bleeding, and infection. Mucositis is a major dose …
dysphagia, diarrhea, weight loss, rectal bleeding, and infection. Mucositis is a major dose …
[HTML][HTML] Vincristine in combination therapy of cancer: emerging trends in clinics
J Škubník, VS Pavlíčková, T Ruml, S Rimpelová - Biology, 2021 - mdpi.com
Simple Summary Vincristine is a vinca alkaloid naturally occurring in Catharanthus roseus. It
belongs to antimitotic compounds, which arrest the cell cycle via disrupting microtubule …
belongs to antimitotic compounds, which arrest the cell cycle via disrupting microtubule …
Chemotherapy induced gastrointestinal toxicities
HI Akbarali, KH Muchhala, DK Jessup… - Advances in cancer …, 2022 - Elsevier
Chemotherapy—induced gastrointestinal dysfunction is a common occurrence associated
with many different classes of chemotherapeutic agents. Gastrointestinal toxicity includes …
with many different classes of chemotherapeutic agents. Gastrointestinal toxicity includes …
Effects of β‐hydroxy β‐methylbutyrate (HMB) supplementation on muscle mass, function, and other outcomes in patients with cancer: a systematic review
Low muscle mass is prevalent among patients with cancer and a predictor of adverse
clinical outcomes. To counteract muscle loss, β‐hydroxy β‐methylbutyrate (HMB) …
clinical outcomes. To counteract muscle loss, β‐hydroxy β‐methylbutyrate (HMB) …
Microbes exploit death-induced nutrient release by gut epithelial cells
Regulated cell death is an integral part of life, and has broad effects on organism
development and homeostasis. Malfunctions within the regulated cell death process …
development and homeostasis. Malfunctions within the regulated cell death process …